Pplus

In 2018 we were granted the Phase I Horizon 2020 SME Instrument funding through the EU Framework Programme for Research and Innovation.

Title: Pplus skin care developing Topical Platelet-rich plasma Kit (TPRPK) in order to facilitate the further development, adoption and implementation of PRP for Healthcare with initial specialisation on cell rejuvenation.

Feasibility Study Report by Pplus Skin Care Limited

Grant Agreement number: 827957

Acronym: TPRPK

Type of the action: H2020-EIC-SMEInst-2018-2020 (Phase1)

Start date of the project: 01/09/2018

Duration of the project: 6 months

In 2019 we were awarded the Horizon 2020 Seal of Excellence.


Pplus